Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
An announcement from Shanghai Pharmaceuticals Holding Co ( (HK:2607) ) is now available.
Shanghai Pharmaceuticals Holding Co., Ltd. has announced an Extraordinary General Meeting (EGM) scheduled for March 13, 2025, to discuss and approve amendments to the company’s Articles of Association and the election of an independent director for its board. This meeting is pivotal for the company as it considers significant governance changes, potentially impacting its decision-making processes and future strategic direction.
More about Shanghai Pharmaceuticals Holding Co
Shanghai Pharmaceuticals Holding Co., Ltd. is a major player in the pharmaceutical industry in China, focusing on the development, manufacturing, and distribution of medicines and healthcare products. The company is known for its comprehensive range of pharmaceutical services and products, catering to both domestic and international markets.
YTD Price Performance: -26.99%
Average Trading Volume: 10,496
Technical Sentiment Consensus Rating: Buy
Current Market Cap: $8.08B
Learn more about 2607 stock on TipRanks’ Stock Analysis page.
